This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.

Search form

Recognizing Leadership to Combat Viral Hepatitis

In the United States, millions of Americans are infected with viral hepatitis, a life-threatening disease, with more than two-thirds unaware of their infection.

Though this disease can affect anyone, viral hepatitis impacts certain communities more than others. African Americans, American Indians, Asian American and Pacific Islanders, the baby boomer generation (those born between 1945 and 1965), and people living with HIV are all disproportionately affected by viral hepatitis. Rates are also higher among people who inject drugs. 

All forms of viral hepatitis pose serious health threats, but building public awareness can help prevent new cases and more effectively treat this epidemic and related health issues such as HIV and substance use disorders.  Thanks to the tireless leadership of researchers and advocates, we are beginning to break the silence surrounding viral hepatitis.

In commemoration of World Hepatitis Day, held annually on July 28, the Office of National Drug Control Policy and Office of National AIDS Policy are honoring national and international efforts to address the “silent epidemic” and achieve the goals of the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis.

In recognition of Leadership in Prevention and Treatment of Viral Hepatitis,


Advancing the Goals of the

Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis


Adrian M. Di Bisceglie, MD

American Association for the Study of Liver Diseases





Barbara Murray, MD

Infectious Disease Society of America





Samuel So, MD

Asian Liver Center, Stanford University School of Medicine





Daniel Raymond

Harm Reduction Coalition




Joan Block, RN, BSN

Hepatitis B Foundation




Michael Ninburg, MPA

Hepatitis Education Project




Julie Scofield

National Alliance of State & Territorial AIDS Directors




Jules Levin, MS

National AIDS Treatment Advocacy Project





Charles Howell, MD

National Medical Association





Holly Hagan PhD, MPH, RN

New York University College of Nursing




Sanjeev Arora, MD

Project ECHO, University of New Mexico





Daniel O’Connell, MA, MLS

New York State Department of Health, AIDS Institute  





Charles Gore

World Hepatitis Alliance





Please join us virtually on Wednesday, July 30, from 12:00 PM to 2:30 PM EST, on as we recognize these leaders and provide a forum for domestic and international stakeholders to strengthen their responses to viral hepatitis and associated issues such as HIV and substance use disorders. The program will feature remarks from senior Federal officials, representatives from international and national organizations, and community leaders, including:

  • Michael Botticelli, Acting Director, National Drug Control Policy
  • Douglas Brooks, Director, White House Office of National AIDS Policy
  • Representative Mike Honda (CA-17), Co-Chair, Congressional Hepatitis Caucus
  • Ambassador Deborah Birx, U.S. Global AIDS Coordinator
  • Dr. Howard Koh, Assistant Secretary for Health
  • Dr. Paul Farmer, Partners in Health